{"id":817648,"date":"2026-07-22T02:20:23","date_gmt":"2026-07-22T02:20:23","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/817648\/"},"modified":"2026-07-22T02:20:23","modified_gmt":"2026-07-22T02:20:23","slug":"fda-greenlights-glenmarks-ryaltris-allergy-spray-for-children-ages-6-12-etpharma","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/817648\/","title":{"rendered":"FDA Greenlights Glenmark&#8217;s Ryaltris Allergy Spray for Children Ages 6-12, ETPharma"},"content":{"rendered":"<p>                                        <img fetchpriority=\"high\" decoding=\"async\" width=\"590\" height=\"442\" class=\"unveil\" loading=\"eager\" style=\"width:100%;max-height:100%\" src=\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/07\/132529120.cms.png\" captionrendered=\"1\" alt=\"\"\/>Mumbai: <a id=\"26542288\" type=\"Denny\" weightage=\"20\" keywordseo=\"Glenmark-Pharmaceuticals\" source=\"keywords\" meta.keywordsubtype=\"org\" meta.entityname=\"Glenmark Pharmaceuticals\" meta.hostid=\"416\" class=\"news-keywords\" href=\"https:\/\/pharma.economictimes.indiatimes.com\/tag\/glenmark+pharmaceuticals\" rel=\"nofollow noopener\" target=\"_blank\">Glenmark Pharmaceuticals<\/a> announced that the US Food and Drug Administration (FDA) has approved the expanded use of its <a id=\"34757894\" type=\"Denny\" weightage=\"20\" keywordseo=\"allergy-nasal-spray\" source=\"keywords\" class=\"news-keywords\" href=\"https:\/\/pharma.economictimes.indiatimes.com\/tag\/allergy+nasal+spray\" rel=\"nofollow noopener\" target=\"_blank\">allergy nasal spray<\/a> <a id=\"34735937\" type=\"Denny\" weightage=\"20\" keywordseo=\"Ryaltris\" source=\"keywords\" class=\"news-keywords\" href=\"https:\/\/pharma.economictimes.indiatimes.com\/tag\/ryaltris\" rel=\"nofollow noopener\" target=\"_blank\">Ryaltris<\/a> for treating <a id=\"32064615\" type=\"Denny\" weightage=\"20\" keywordseo=\"pediatric-patients\" source=\"keywords\" class=\"news-keywords\" href=\"https:\/\/pharma.economictimes.indiatimes.com\/tag\/pediatric+patients\" rel=\"nofollow noopener\" target=\"_blank\">pediatric patients<\/a> aged 6 to 12 years.<\/p>\n<p>The approval was supported by a Phase 3 study involving 446 children aged 6 to 11 years, where the drug demonstrated an improvement in nasal symptoms over a 14-day period compared to placebo.<\/p>\n<p>\u201cThis approval marks an important step in expanding access to Ryaltris  and strengthens the drug as a key innovative brand within Glenmark\u2019s growing US respiratory portfolio,\u201d said Marc Kikuchi, President and Business Head, North America, Glenmark.<\/p>\n<p>Ryaltris ia a fixed-dose combination of olopatadine hydrochloride (an antihistamine) and mometasone furoate (a corticosteroid), approved for treating symptoms associated with Seasonal Allergic Rhinitis.<\/p>\n<p>Presently the brand is marketed across 55 countries and ranks among the company\u2019s best-selling assets with an estimated annual turnover of $100 million.<\/p>\n<p>In April this year, Glenmark announced to take full control of the drug\u2019s commercialisation and distribution in the US, shifting away from the local partnership with Hikma Pharma, since its launch in 2022.<\/p>\n<p>Glenmark termed the move an effort \u201cto enable more focused execution and better align its commercial strategy with the needs of healthcare professionals and patients.\u201d\n                                                                    <\/p>\n<p>                                    Published On Jul 21, 2026 at 11:34 AM IST<\/p>\n<p>\n                Join the community of 2M+ industry professionals.<br \/>\n                Subscribe to Newsletter to get latest insights &amp; analysis in your inbox.\n            <\/p>\n<p>                    All about ETPharma industry right on your smartphone! <\/p>\n<p>                        <img decoding=\"async\" loading=\"lazy\" width=\"90\" height=\"90\" src=\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/07\/1784686823_373_pharma_barcode.png\" alt=\"\"\/>                        <\/p>\n","protected":false},"excerpt":{"rendered":"Mumbai: Glenmark Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved the expanded use of&hellip;\n","protected":false},"author":2,"featured_media":817649,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[286692,49,48,146541,84,377,34013,286691,274078],"class_list":["post-817648","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-allergy-nasal-spray","tag-ca","tag-canada","tag-glenmark-pharmaceuticals","tag-health","tag-medication","tag-pediatric-patients","tag-ryaltris","tag-us-fda-approval"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/817648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=817648"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/817648\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/817649"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=817648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=817648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=817648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}